BioCentury
ARTICLE | Clinical News

ACTOplus met XR pioglitazone/extended-release metformin regulatory update

May 18, 2009 7:00 AM UTC

FDA approved extended-release ACTOplus met XR to treat Type II diabetes in adults already receiving Actos pioglitazone and metformin or who have inadequate glycemic control on Actos or metformin alon...